Key clinical point: Delivered by injection, alcohol-based renal denervation was associated with efficacy and safety in pilot study.
Major finding: At six months, mean 24-hour ambulatory systolic blood pressure was reduced 11 mmHg.
Data Source: Open label study.
Disclosures: Dr. Sievert did not include Ablative Solutions, the developer of the Peregrine System Kit, on a list of pharmaceutical and device manufacturers with which he has financial relationships.
2019 Cardiovascular Research Technologies.